Catheter lock to prevent infections in newborns
Part of Genetic & congenital, Infections clinical trials.
This study tests a special fluid used to flush the catheter (called a 'lock') to see if it can prevent infections in newborns. If your baby has a central line, this could help reduce the risk of serious infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby has a central venous catheter (a special IV line placed in a large vein) that has been in place for at least 48 hours.
- Your baby has not received antibiotics in the 48 hours before starting the study.
- Your baby does not have an umbilical venous catheter (a line placed in the belly button).
- Your baby has not been diagnosed with a condition that increases the risk of blood clots.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new method to prevent infections from central lines (special IVs placed in large veins) in intensive care units. If you have a central line in place for more than 24 hours, this research may help improve your safety by finding better ways to avoid catheter-related bloodstream infections.
This study compares two types of central lines used in sick newborns: one placed in the belly button (UVC) and one placed in an arm or leg vein (PICC). It looks at which type is safer, lasts longer, and causes fewer bloodstream infections.
This study is looking at infections from central lines (special IVs in large veins) in ICU patients across China. It aims to understand how common these infections are and what factors contribute to them.
This study tests a catheter lock solution called DefenCath (taurolidine and heparin) against a standard heparin lock to see if it reduces central line bloodstream infections in people receiving IV nutrition (total parenteral nutrition) for more than 3 months.
This trial studies whether a medicine lock called taurolidine is safer or works better than a standard saline (salt water) lock for pediatric cancer patients with central venous lines. It’s meant to help prevent central-line infections.
This study tests a liquid that is put into the dialysis catheter after each session to prevent infections that can happen through the catheter. It is designed for children up to age 18 who need hemodialysis through a catheter.
Hear when a new CLABSI - Central Line Associated Bloodstream Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.